Finance

Lists
506820:BOM
Astrazeneca Pharma India Ltd
₹5 943,85
+0,36%
(+21,25) 1D
16 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 506820...
Open
₹5 930,00
High
₹5 985,10
Low
₹5 860,50
Mkt. cap
149,26 mjd
Avg. vol.
525,00
Volume
117,00
Dividend
0,61%
Quarterly dividend
₹9,00
Ex-dividend date
31 Jul. 2026
P/E ratio
87,61
52-wk high
₹9 850,00
52-wk low
₹5 660,00
EPS
₹67,85
Shares outstanding
25,00 m
No. of employees
760
Open
₹5 930,00
High
₹5 985,10
Low
₹5 860,50
Mkt. cap
149,26 mjd
Avg. vol.
525,00
Volume
117,00
Dividend
0,61%
Quarterly dividend
₹9,00
Ex-dividend date
31 Jul. 2026
P/E ratio
87,61
52-wk high
₹9 850,00
52-wk low
₹5 660,00
EPS
₹67,85
Shares outstanding
25,00 m
No. of employees
760
News stories
From web sources and news partners
About Astrazeneca Pharma India Ltd
CEO-
Employees760
Founded1979
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
5,59 mjd
6,12 mjd
5,79 mjd
6,83 mjd
Cost of goods sold
3,24 mjd
3,66 mjd
3,98 mjd
4,47 mjd
Cost of revenue
3,24 mjd
3,66 mjd
3,98 mjd
4,47 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
884,60 m
1,30 mjd
-392,20 m
1,10 mjd
Operating expense
1,62 mjd
2,04 mjd
1,25 mjd
1,92 mjd
Total operating expenses
4,86 mjd
5,71 mjd
5,23 mjd
6,39 mjd
Operating income
726,10 m
409,90 m
556,00 m
437,10 m
Other non operating income
61,70 m
51,30 m
-175,20 m
92,30 m
EBT including unusual items
728,20 m
465,40 m
581,40 m
507,50 m
EBT excluding unusual items
781,10 m
450,60 m
593,50 m
509,90 m
Income tax expense
186,00 m
139,50 m
132,60 m
128,20 m
Effective tax rate
25,54%
29,97%
22,81%
25,26%
Other operating expenses
655,10 m
694,70 m
1,49 mjd
741,30 m
Net income
542,20 m
325,90 m
448,80 m
379,30 m
Net profit margin
9,70%
5,33%
7,76%
5,56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
232,00 m
-
Interest expense
-6,70 m
-10,60 m
-20,40 m
-19,50 m
Net interest expenses
-6,70 m
-10,60 m
211,60 m
-19,50 m
Depreciation and amortization charges
25,70 m
38,40 m
56,00 m
52,30 m
EBITDA
821,80 m
493,98 m
598,30 m
479,40 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme